Clinical Trial Update: Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating radiotherapy in combination with ipilimumab for unresectable stage III or stage IV malignant melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Malignant Melanoma | Phase 1 | Status: TERMINATED